Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
03/2003
03/06/2003WO2002012987A3 Systems and methods for authenticating a user to a web server
03/06/2003WO2002012325A3 Suppressor gene
03/06/2003WO2002012281A9 Molecular vaccine linking an endoplasmic reticulum chaperone polypeptide to an antigen
03/06/2003WO2002007675A3 Omega-conopeptides
03/06/2003WO2002006501A3 Method for altering degradation of engineered protein in plant cells
03/06/2003WO2002006478A8 Extracellular matrix protein
03/06/2003WO2002004018A8 Mid-life vaccine and methods for boosting anti-mycobacterial immunity
03/06/2003WO2002002602A9 Slgp protein and nucleic acid molecules and uses therefor
03/06/2003WO2002000841A9 58199, a membrane-associated protein and uses therefor
03/06/2003WO2001098343A9 Conserved diaphanous-related formin autoregulatory domain (dad)
03/06/2003WO2001096394A3 Pleiotrophin growth factor receptor for the treatment of proliferative, vascular and neurological disorders
03/06/2003WO2001092525A8 Compositions and methods for the therapy and diagnosis of lung cancer
03/06/2003WO2001092304A3 Transporters and ion channels
03/06/2003WO2001086293A8 A method for designing and screening random libraries of compounds
03/06/2003WO2001077146A3 Compounds and methods for modulating endothelial cell adhesion
03/06/2003WO2001075105A9 Human leucine-rich repeat family member and uses thereof
03/06/2003WO2001074900A9 Nuclear factor kb inducing factor
03/06/2003WO2001072781A9 Human genes and expression products
03/06/2003WO2001066741A9 Kcnb: a novel potassium channel protein
03/06/2003WO2001066596A9 Human fgf-23 gene and gene expression products
03/06/2003WO2001062924A9 Human g protein-coupled receptors
03/06/2003WO2001055393A9 Mhc class ii restricted t cell epitopes from the cancer antigen ny-eso-1
03/06/2003WO2001038488A3 Gene expression by positive feedback activation of a cell type-specific promoter
03/06/2003US20030046729 Isolated nucleic acid molecules encoding Na+/H+ exchanger polypeptides for extrusion of monovalent cations, most preferably sodium ions from the cytosol of cells to provide the cell with increased salt tolerance
03/06/2003US20030046728 Compositions isolated from plant cells and their use in the modification of plant cell signaling
03/06/2003US20030046727 Arcelin-5 promoter and uses thereof
03/06/2003US20030046726 Encode for insecticidal polypeptides, particularly insecticidal proteins from Bacillus thuringiensis
03/06/2003US20030046723 Recombinant polynucleotides and methods for altering the regulation of gene expression in plants are provided to modify plant's traits, in particular disease tolerance
03/06/2003US20030046719 Transgenic mice comprising mutations in a proliferator-activated receptor gene; methods for identifying agents that modulate proliferator-activated receptor expression and function, and potential treatments for disease
03/06/2003US20030046718 Administering compounds having an effect on cardiac fibrosis, myocardial infarction, defects in electrical conductance, atherosclerosis, unstable plaque, and stroke in an animal which does not express an active SR-BI, and an apolipoprotein
03/06/2003US20030046717 Isolated nucleic acid that encodes a Patched like transmembrane protein, functioning in male germ cell development, and as a potential tumor suppressor
03/06/2003US20030046716 Providing transgenic mammal whose somatic and germ cells comprise nucleic acid sequence encoding PDGF operably linked to promoter which directs expression into mammary gland epithelial cells and obtaining milk from animal
03/06/2003US20030046715 H2-O modified transgenic animals
03/06/2003US20030046714 Anti-neovasculature preparations for cancer
03/06/2003US20030045746 Phosphorous organic compounds and their use
03/06/2003US20030045704 Chromosome 17p-linked prostrate cancer susceptibility gene and a paralog and orthologous genes
03/06/2003US20030045703 Novel forms of T cell costimulatory molecules and uses therefor
03/06/2003US20030045702 Secreted Chlamydia polypeptides and method for identifying such polypeptides by their secretion by a type III secretion pathway of a gram-negative bacteria
03/06/2003US20030045701 Polynucleotide constructs and methods of expression in a host cell
03/06/2003US20030045700 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/06/2003US20030045699 Nucleotide sequences coding polypeptide for use in the treatment of osteoporosis, benign prostate hyperplasia, cardiovascular, vascular, nervous system and inflammatory disorders
03/06/2003US20030045697 Regulatable growth of filamentous fungi
03/06/2003US20030045696 Nucleotide sequences coding polypeptide for use in the treatment of diarrhea, nausea, fever, pain, and inflammation
03/06/2003US20030045693 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/06/2003US20030045690 Having a mean diameter of 200-2000 nm, obtained by solidification from a mixture comprising fibrinogen, thrombin and Factor XIII in an water in oil emulsion
03/06/2003US20030045689 Gelling vegetable protein
03/06/2003US20030045687 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative and tumor disorders
03/06/2003US20030045686 Mutein polypeptide for use in the treatment of hypoxia and ischemic related tissue damages
03/06/2003US20030045685 Nucleotide sequences coding polypeptide for use in the treatment of cancer, psoriasis, inflammatory bowel disease and hyperlipidemia
03/06/2003US20030045684 Polypeptide for use in humans therapeutics and diagnostics
03/06/2003US20030045683 H14 DNA and polypeptides
03/06/2003US20030045682 Antibodies immunospecific for STEAP1
03/06/2003US20030045680 Peptidic modulators of the androgen receptor
03/06/2003US20030045679 Peptide for use in the treatment of cancer and alzheimer's disease
03/06/2003US20030045678 Crystalline or crystal-like lipopeptide for use as bactericides
03/06/2003US20030045677 Isolation of glycoproteins from bovine milk
03/06/2003US20030045676 Peptides, antibodies, vaccines & uses thereof
03/06/2003US20030045602 Methods for purification of an activated PEG solution and for the synthesis of a modified hemoglobin solution
03/06/2003US20030045498 Contacting the ocular cell with an expression vector comprising the nucleic acid sequence encoding the inhibitor of angiogenesis and the nucleic acid sequence encoding the neurotrophic agent.
03/06/2003US20030045489 Administering anti-angiogenic FGF-19 polypeptides or an anti-angiogenic FGF-19 nucleic acid to inhibit angiogenesis; antitumor agents
03/06/2003US20030045485 Reducing the viability of a proliferating mammalian cells such as cancer cells by increasing the level or activity of p53 in the cell.
03/06/2003US20030045484 Crystallizing amorphous daptomycin from a crystallization solution comprising a cation from a salt, a buffer, an organic precipitant, and a low molecular weight alcohol.
03/06/2003US20030045477 Peptides having antiangiogenic activity
03/06/2003US20030045472 Controlling insect populations.
03/06/2003US20030045471 DNA molecules encoding vascular endothelial cell growth factor II subunits
03/06/2003US20030045470 Methods and compositions for modulating gluconeogenesis using PGC-1
03/06/2003US20030045468 Polypeptide comprising at least 7 consecutive amino acid residues of human mammaglobin, wherein no more than 30 consecutive residues of human mammaglobin are present
03/06/2003US20030045466 Calcium binding protein
03/06/2003US20030045465 RTransport polymer comprising a linear or branched peptide having 10-300 amino acid residues, having from about 5 to 100% histidine residues; drug delivery, especially gene therapy and cancer chemotherapy
03/06/2003US20030045464 From a crystallization solution comprising a GLP, a buffering agent, an alcohol or a mono or disaccharide, and optionally, ammonium sulfate or zinc.
03/06/2003US20030045463 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/06/2003US20030045462 Also vectors and host cells comprising those nucleic acid sequences, chimeric molecules of these polypeptides fused to heterologous polypeptide sequences, antibodies which bind to these polypeptides
03/06/2003US20030045460 Orally administered peptides to ameliorate atherosclerosis
03/06/2003US20030045459 67 Human secreted proteins
03/06/2003US20030045453 Pharmaceutical composition for stimulation of the immune system
03/06/2003US20030044982 Expression vector coding blood coagulation protein for use in the treatment of blood disorders
03/06/2003US20030044981 Pseudotyped lentiviral vectors and uses thereof
03/06/2003US20030044975 Cytokine-binding domain for use in the treatment of asthma and thrombocytopenia
03/06/2003US20030044973 Mammalian adrenocorticotropic hormone receptors and uses
03/06/2003US20030044972 Maize chloroplast protein synthesis elongation factors and methods of use for same
03/06/2003US20030044960 Picornaviruses, vaccines and diagnostic kits
03/06/2003US20030044959 Chromosome 17p-linked prostrate cancer susceptibility gene and a paralog and orthologous genes
03/06/2003US20030044958 Nucleotide sequences coding polypeptide for use in monitoring and treating inflammatory disorders
03/06/2003US20030044957 Zinc finger proteins for DNA binding and gene regulation in plants
03/06/2003US20030044946 Genes, mutations, and drugs that increase cellular resistance to damage and extend longevity in organisms from yeast to humans
03/06/2003US20030044945 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/06/2003US20030044937 Nucleotide sequences coding polypeptide for use in the treatment of inflammation and cancer
03/06/2003US20030044936 Peptide repeat immunogens
03/06/2003US20030044935 Secreted proteins and polynucleotides encoding them
03/06/2003US20030044934 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative disorders
03/06/2003US20030044933 Nucleotide sequences coding polypeptides for use in the treatment of cell proliferative, cardiovascular, nervous system, bone, inflammatory, endothelial, liver, viral, pain and metabolic disorders
03/06/2003US20030044932 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative disorders
03/06/2003US20030044931 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative disorders
03/06/2003US20030044930 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/06/2003US20030044929 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/06/2003US20030044928 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative disorders
03/06/2003US20030044927 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative disorders
03/06/2003US20030044926 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/06/2003US20030044925 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/06/2003US20030044924 Secreted and transmembrane polypeptides and nucleic acids encoding the same
1 ... 1654 1655 1656 1657 1658 1659 1660 1661 1662 1663 1664 1665 1666 1667 1668 1669 1670 1671 1672 1673 1674 ... 2916